electroCore to Present at the 13th Annual LD Micro Main Event Conference
BASKING RIDGE, N.J., Dec. 07, 2020 – electroCore, a bioelectronic medicine company (Nasdaq: ECOR), will present at the 13th Annual LD Micro Main Event Conference on December 14, 2020. The presentation is scheduled for 2:40-3:00 PM EDT. Investors can register for the conference HERE. A webcast replay will be available on the company's website post-conference. electroCore focuses on non-invasive vagus nerve stimulation therapy for migraines and cluster headaches.
- None.
- None.
BASKING RIDGE, N.J., Dec. 07, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that management is scheduled to present at the 13th Annual LD Micro Main Event Conference.
Presentation details:
Date: Monday, December 14, 2020
Time: 2:40-3:00pm EDT
Investors can register for the conference HERE.
Following the conference a webcast replay of the presentation will be available on the Investor section of the company’s website, www.electrocore.com.
About electroCore, Inc.
electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.
For more information, visit www.electrocore.com.
Investors:
Hans Vitzthum
LifeSci Advisors
617-430-7578
hans@lifesciadvisors.com
or
Media Contact:
Jackie Dorsky
electroCore
973-290-0097
jackie.dorsky@electrocore.com
FAQ
What is the date and time of electroCore's presentation at the LD Micro Main Event Conference?
Where can I register for the LD Micro Main Event Conference to see electroCore's presentation?
What therapy does electroCore specialize in?
Will there be a replay of electroCore's presentation after the conference?
